Research News

17 New Genetic Variants Linked To Parkinson’s Disease

Sunday, 17 September 2017

A little more than 20 years ago, we thought Parkinson’s had no genetic connection. Today scientists have a growing list of genetic variants and mutations linked to the disease. While we’ve learned a lot in two decades, we know there…

Parkinson's research

Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

Sunday, 10 September 2017

Voyager Therapeutics today announced positive interim results from an ongoing Phase Ib, open-label trial testing a gene therapy that helps the brain make dopamine from levodopa, the gold standard treatment for Parkinson’s symptoms. After a one-time surgical procedure to deliver therapy directly…

Parkinson's Puzzle

Can you Help us Solve the Parkinson’s Puzzle?

Saturday, 2 September 2017

It is estimated that over 120,000 Australians will be living with Parkinson’s by 2034 and there are currently no treatments available to prevent, slow, halt or reverse the condition. Treatments currently available assist in controlling symptoms but often have very…

Stem Cells in Parkinson's

Stem Cells Safe in Pre-Clinical Parkinson’s Disease Study

Thursday, 31 August 2017

A new stem cell study, published in the journal Nature, builds on the potential for this therapy in Parkinson’s, but it’s still early days and much work remains to be done. A team of researchers demonstrated that human induced pluripotent stem…

New Dyskensia Drug FDA Approved

FDA Approval for New Drug to Treat Levodopa Induced Dyskinesia

Monday, 28 August 2017

Adamas Pharmaceuticals yesterday announced U.S. Food and Drug Administration (FDA) approval of an extended-release formulation of amantadine (GOCOVRI) to treat dyskinesia in Parkinson’s disease (PD). This is the first drug indicated specifically for dyskinesia — uncontrolled, involuntary movements that can develop with…

Dr Richard Gordon research into Parkinson's disease

Under the Microscope: Dr Richard Gordon

Sunday, 20 August 2017

Shake It Up has a clear mission; to find the cure for Parkinson’s. To achieve this we invest in Australia’s leading Parkinson’s research.We are fortunate to have a dedicated family of supporters who so generously donate and/or fundraise enabling us to…

Nic Dzamko - University of Sydney Parkinson's research

Under the microscope: Dr Nicolas Dzamko

Thursday, 10 August 2017

In this week’s Under the Microscope, we feature Dr Nicolas Dzamko. Based at The University of Sydney he is currently working alongside Professor Glenda Halliday on several exciting Parkinson’s research projects. Briefly outline where you commenced your research journey and…

Parkinson's Reseach at university of Queensland

Alpha-synuclein Research Progress for Parkinson’s

Saturday, 1 July 2017

As researchers search for a therapy to slow or stop Parkinson’s disease (PD) progression, alpha-synuclein has emerged as a leading target. This protein clumps in the brains of nearly everyone with Parkinson’s and it’s the primary component of Lewy bodies,…

Study to Understand Exercise Preferences in Parkinson’s disease

Wednesday, 28 June 2017

The University of Sydney invites you to take part in a research study about the exercise preferences of people with Parkinson’s disease. Summary There is increasing evidence supporting the benefits of exercise for people with Parkinson’s disease (PD). Exercise improves motor…

Neurons

Could Parkinson’s disease be an autoimmune disorder?

Monday, 26 June 2017

Could Parkinson’s disease be an autoimmune disorder? A recent study from Columbia University revealed a possible link between the immune system — the body’s defense system against disease — and alpha-synuclein, the sticky protein that clumps in the cells of…